Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Here’s why the Bubs (ASX:BUB) share price jumped 7% today

The Bubs Australia Ltd (ASX: BUB) share price has jumped 7% in early morning trade after announcing a 73% uplift in first-half revenue. 

The Bubs Australia Ltd (ASX: BUB) share price has jumped 7% in early morning trade after announcing a 73% uplift in first-half revenue.

Bubs is an Australian producer of infant nutrition and dairy products derived from goats milk.

BUB share price

Source: Rask Media BUB 2-year share price
Source: Rask Media BUB 2-year share price

China market roars back to life

Key highlights for the first-half include:

  • Gross revenue of $38.5 million, soaring 73% year-on-year (YoY)
    • Record second-quarter revenue of $19.9 million, up 56% YoY
  • Free cash flow of $2.7 million
  • Cash of $30.6 million

The key driver of first-half sales growth was a 121% bump in China revenue, which contributes 60% of Bub’s total sales.

“For our China facing business, our response to the pandemic impact and decision to realign our China sales channels to execute ‘Bubs Daigou 2.0’ strategy has been validated”

“Working alongside our strategic channel partner, AZ Global, we focused on enhancing channel engagement and campaign activation, whilst maintaining stabilised pricing and balanced fresh inventory levels”

The corporate daigou channel recorded a 196% uplift YoY.

Sales now exceed pre-pandemic levels, indicating demand may be normalising after a difficult two years for importers.

Q4 FY20: Why the Bubs (ASX: BUB) share price is down

China sales were also aided by strong performance on cross-border e-commerce and its adult brand CapriLac.

“Bubs Goat Infant Formula achieved the number one share position for imported Australian goat formula brands on JD Global⁵ and Tmall TDI”

The positive free cash flow result – a common measure of profitability – demonstrates that when Bubs scales it can begin to produce profits.

No laggards

Bubs also benefitted from a 9% increase in domestic retail and a 66% growth in the international market (ex-China).

Bubs is now the fastest growing infant formula manufacturer across major supermarkets Woolworths, Coles and Chemist Warehouse.

ASX infant formula wars: a2 Milk vs. Bubs vs. Nuchev

Scan rates across the three outlets are up 31% YoY and now represents a 3.9% market share.

During the half, Bubs went live on popular USA retail sites Walmart, Amazon and Thrive.

My take

Today’s trading update was impressive, given the tough market difficult conditions.

Furthermore, while big bro A2 Milk Company Ltd (ASX: A2M) continues to struggle, Bubs is setting records.

I’d have to do more research into the company.

But with Bubs share price still lingering near two-year lows, it could be one for the watchlist.

To keep up to date on all the latest news regarding Bubs and its half-year report in February, be sure to bookmark the Rask Media home page.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.
Skip to content